NASCAR is partnering with Regeneron to educate people on the two most common forms of advanced non-melanoma skin cancer.

Skin cancer is the most common type of cancer in the U.S., and it has increased dramatically in the last 50 years. Melanoma, ...

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

With more people out and about enjoying themselves in the summer sun, experts are advising people to protect themselves from ...

A rare case of skin cancer in a 55-year-old xeroderma pigmentosum patient highlights the persistent, lifelong risk of UV-induced malignancies in this photosensitive genodermatosis.